These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469 [TBL] [Abstract][Full Text] [Related]
44. Autologous stem cell transplantation for T and null cell CD30-positive anaplastic large cell lymphoma: analysis of 64 adult and paediatric cases reported to the European Group for Blood and Marrow Transplantation (EBMT). Fanin R; Ruiz de Elvira MC; Sperotto A; Baccarani M; Goldstone A Bone Marrow Transplant; 1999 Mar; 23(5):437-42. PubMed ID: 10100556 [TBL] [Abstract][Full Text] [Related]
45. Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey. Jantunen E; Wiklund T; Juvonen E; Putkonen M; Lehtinen T; Kuittinen O; Franssila K; Söderström KO; Leppä S; Elonen E; Remes K; Nousiainen T Bone Marrow Transplant; 2004 Feb; 33(4):405-10. PubMed ID: 14676776 [TBL] [Abstract][Full Text] [Related]
46. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853 [TBL] [Abstract][Full Text] [Related]
47. Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review. Ayash LJ; Clarke M; Silver SM; Braun T; Uberti J; Ratanatharathorn V; Reynolds C; Ferrara J; Broun ER; Adams PT Bone Marrow Transplant; 2001 May; 27(9):939-47. PubMed ID: 11436104 [TBL] [Abstract][Full Text] [Related]
48. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Schaaf M; Reiser M; Borchmann P; Engert A; Skoetz N Cochrane Database Syst Rev; 2012 Jan; 1(1):CD007678. PubMed ID: 22258971 [TBL] [Abstract][Full Text] [Related]
49. High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. Eide MB; Lauritzsen GF; Kvalheim G; Kolstad A; Fagerli UM; Maisenhölder M; Østenstad B; Fluge Ø; Delabie J; Aarset H; Liestøl K; Holte H Br J Haematol; 2011 Mar; 152(5):600-10. PubMed ID: 21241276 [TBL] [Abstract][Full Text] [Related]
50. Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma. Arcaini L; Morello L; Tucci A; Rusconi C; Ladetto M; Rattotti S; Bonfichi M; Bottelli C; Gabutti C; Bernasconi P; Varettoni M; Gotti M; Troletti D; Guerrera ML; Fiaccadori V; Sciarra R; Ferretti VV; Alessandrino EP; Rossi G; Morra E Am J Hematol; 2015 Mar; 90(3):230-4. PubMed ID: 25502635 [TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics and outcomes of relapsed follicular lymphoma after autologous stem cell transplantation in the rituximab era. Sesques P; Bourcier J; Golfier C; Lebras L; Nicolas-Virelizier E; Hacini M; Perrin MC; Voillat L; Bachy E; Traverse-Glehen A; Moreau A; Martin L; Ramla S; Casasnovas O; Le Gouill S; Salles G; Ghesquières H Hematol Oncol; 2020 Apr; 38(2):137-145. PubMed ID: 31953963 [TBL] [Abstract][Full Text] [Related]
52. [The impact of autologous stem cell transplantation on the prognosis in multiple myeloma]. Li YH; Hou J; Wang DX; Fu WJ; Yuan ZG; Chen YB; Xi H Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):222-5. PubMed ID: 18843973 [TBL] [Abstract][Full Text] [Related]
53. Primary mediastinal large cell lymphoma (PMBL): frontline treatment with autologous stem cell transplantation (ASCT). The GEL-TAMO experience. Rodríguez J; Conde E; Gutiérrez A; García JC; Lahuerta JJ; Varela MR; Pérez C; Albo C; Caballero MD Hematol Oncol; 2008 Sep; 26(3):171-8. PubMed ID: 18432630 [TBL] [Abstract][Full Text] [Related]
54. [Dose-intensive immunochemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of 29 newly diagnosed young patients with medium/high risk diffuse large B-cell lymphoma]. Yi S; Liu W; Lyu R; Li Z; Xu Y; Sui W; Huang W; Wang T; Deng S; Liu H; Fu M; Zou D; Qiu L Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):546-50. PubMed ID: 24985182 [TBL] [Abstract][Full Text] [Related]
55. Rituximab purging and/or maintenance in patients undergoing autologous transplantation for relapsed follicular lymphoma: a prospective randomized trial from the lymphoma working party of the European group for blood and marrow transplantation. Pettengell R; Schmitz N; Gisselbrecht C; Smith G; Patton WN; Metzner B; Caballero D; Tilly H; Walewski JA; Bence-Bruckler I; To B; Geisler CH; Schots R; Kimby E; Taverna CJ; Kozák T; Dreger P; Uddin R; Ruiz de Elvira C; Goldstone AH J Clin Oncol; 2013 May; 31(13):1624-30. PubMed ID: 23547078 [TBL] [Abstract][Full Text] [Related]
56. The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls. Hill BT; Rybicki L; Bolwell BJ; Smith S; Dean R; Kalaycio M; Pohlman B; Tench S; Sobecks R; Andresen S; Copelan E; Sweetenham J Br J Haematol; 2011 Mar; 152(5):561-9. PubMed ID: 21223255 [TBL] [Abstract][Full Text] [Related]
57. Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experience. Bourcier J; Gastinne T; Leux C; Moreau A; Bossard C; Mahé B; Blin N; Dubruille V; Touzeau C; Voldoire M; Guillaume T; Peterlin P; Gallas P; Garnier A; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Chevallier P; Moreau P; Le Gouill S Ann Hematol; 2016 Aug; 95(8):1287-93. PubMed ID: 27297970 [TBL] [Abstract][Full Text] [Related]